Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why Investors Are Buzzing About NXP Semiconductors, Ophthotech, Trina Solar, and Two Other Stocks

Page 1 of 2

Although much of the market’s attention is on Twitter Inc (NYSE:TWTR) after various reports said that several ideal matches won’t bid for the social media company, traders are also paying attention to four tech stocks and one biotech today.

In this article, we will find out why investors are keenly watching the price action associated with NXP Semiconductors NV (NASDAQ:NXPI), QUALCOMM, Inc. (NASDAQ:QCOM), Ophthotech Corp (NASDAQ:OPHT), JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), and Trina Solar Limited (ADR) (NYSE:TSL) and we’ll use data from the last round of 13F filings to get an idea what smart money investors think about the companies in question.

At Insider Monkey, we track around 740 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on, can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see the details here).

information, microchip, system, background, tech, network, transistor, closeup, dust, power, processor, old, digital, circuit, technology, computer, macro, microprocessor,

Portogas D Ace/

Although sources say that no deal is imminent, the potential marriage between NXP Semiconductors NV (NASDAQ:NXPI) and QUALCOMM, Inc. (NASDAQ:QCOM) is moving forward. According to CNBC Now, the two semi-conductor companies are holding talks concerning a merger, and the former has asked for $120 per share as the take-out price. Although that is around a 20% premium from NXP’s current price, some analysts think that QUALCOMM could go through with the deal and still unlock substantial value for its own shareholders. David Tepper’s Appaloosa Management initiated a new stake of 1.4 million shares in NXP Semiconductors NV (NASDAQ:NXPI) during the second quarter. Meanwhile, Ken Fisher’s Fisher Asset Management inched up its holdings in QUALCOMM, Inc. (NASDAQ:QCOM) by 2% during the same time frame to 9.68 million shares held at the end of June.

Follow Qualcomm Inc (NASDAQ:QCOM)
Trade (NASDAQ:QCOM) Now!

Follow N X P Semiconductors N V (NASDAQ:NXPI)
Trade (NASDAQ:NXPI) Now!

Ophthotech Corp (NASDAQ:OPHT) shares are 2% in the red after Terence Flynn, analyst at Goldman Sachs, cut his price target on the stock to $23 per share from $45 and reiterated his ‘Sell’ rating, saying that he is more cautious on the success of Ophthotech’s lead product candidate, Fovista, (which is currently in Phase 3 clinical trials) after the release of disappointing Phase 2 data by peer Regeneron Pharmaceuticals Inc (NASDAQ:REGN). On September 30, Regeneron announced that a Phase 2 study of Aflibercept co-formulated with Rinucumab showed no benefit over Aflibercept alone for patients with neovascular age-related macular degeneration. A total of 27 funds from our database had a bullish position in Ophthotech Corp (NASDAQ:OPHT) at the end of June, up by three funds from the previous quarter.

Follow Ophthotech Corp. (NASDAQ:OPHT)
Trade (NASDAQ:OPHT) Now!

On the next page, we find out why investors are buzzing about JA Solar Holdings, and Trina Solar Limited.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!